GBA1 and Parkinson disease: These findings were confirmed by shotgun lipidomics of L444PGBA mutation fibroblasts, an ex vivo PD system that presents a mutation of the GBA gene, showing distinct, increased proportions of ceramides and hexosylceramide, while total phospholipids were significantly decreased [95].